OTCMKTS:GNGBY Getinge (GNGBY) Stock Price, News & Analysis $27.90 -0.21 (-0.73%) As of 11/13/2026 12:09 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsNews and TrendsShort Interest About Getinge Stock (OTCMKTS:GNGBY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Getinge alerts:Sign Up Key Stats Today's Range$27.90▼$27.9050-Day Range$23.93▼$28.7052-Week Range$18.99▼$28.83Volume338 shsAverage Volume647 shsMarket Capitalization$7.60 billionP/E Ratio25.36Dividend Yield1.00%Price TargetN/AConsensus RatingHold Company Overview Getinge is a Swedish medical technology company that develops products and services for hospitals and life science organizations. Its offerings support patient care, surgical procedures, infection prevention and the production of medicines and other biological products. The company’s portfolio includes equipment and solutions for intensive care, cardiovascular procedures and operating rooms, as well as sterilization and cleaning systems. Its life science business provides solutions used in areas such as pharmaceutical and biotechnology manufacturing. Founded in 1904 in the Swedish town of Getinge, the company is headquartered in Gothenburg and serves customers in markets around the world. Mattias Perjos has served as Getinge’s president and chief executive officer since 2017.AI Generated. May Contain Errors. Read More Getinge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreGNGBY MarketRank™: 3.224980299445 of 5 starsGetinge scored higher than 64% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.8 / 5Analyst RatingHold Consensus RatingGetinge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageGetinge has only been the subject of 4 research reports in the past 90 days.Read more about Getinge's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.09% Earnings GrowthEarnings for Getinge are expected to grow by 8.09% in the coming year, from $1.36 to $1.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Getinge is 25.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.40.Price to Earnings Ratio vs. SectorThe P/E ratio of Getinge is 25.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.56.Price to Book Value per Share RatioGetinge has a P/B Ratio of 2.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Getinge's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Getinge has been sold short.Short Interest Ratio / Days to CoverGetinge has a short interest ratio ("days to cover") of 0.85, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend2.5 / 5Dividend StrengthModerate Dividend YieldGetinge pays a meaningful dividend of 1.03%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGetinge does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Getinge is 25.45%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Getinge will have a dividend payout ratio of 19.05% next year. This indicates that Getinge will be able to sustain or increase its dividend.Read more about Getinge's dividend. News and Social Media2.2 / 5News Sentiment0.52 News SentimentGetinge has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Getinge this week, compared to 0 articles on an average week. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Getinge insiders have not sold or bought any company stock.Percentage Held by InstitutionsGetinge has minimal institutional ownership at this time.Read more about Getinge's insider trading history. Receive GNGBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Getinge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNGBY Stock News HeadlinesGetinge Establishes Sustainable Financing FrameworkNovember 12 at 8:30 AM | tipranks.comGetinge Appoints Stacy Beske to Lead Acute Care TherapiesNovember 9, 2026 | tipranks.comMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.November 15 at 1:00 AM | Weiss Ratings (Ad)Getinge Announces Leadership Change in Acute Care Therapies DivisionOctober 26, 2026 | tipranks.comGetinge AB Earnings Call Signals Steady Margin ClimbOctober 25, 2026 | tipranks.comGetinge AB Earnings Call: Margins Rise Amid HeadwindsOctober 21, 2026 | tipranks.comGetinge Industrier AB ADR Stock Price HistoryOctober 21, 2026 | investing.comGetinge lifts margins and cash flow as new critical-care products roll outOctober 21, 2026 | tipranks.comSee More Headlines GNGBY Stock Analysis - Frequently Asked Questions How have GNGBY shares performed this year? Getinge's stock was trading at $23.65 at the start of the year. Since then, GNGBY stock has increased by 18.0% and is now trading at $27.90. How were Getinge's earnings last quarter? Getinge (OTCMKTS:GNGBY) issued its quarterly earnings results on Wednesday, October, 21st. The company reported $0.32 earnings per share (EPS) for the quarter. The business had revenue of $875.58 million for the quarter. Getinge had a trailing twelve-month return on equity of 11.55% and a net margin of 8.20%. How do I buy shares of Getinge? Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings10/21/2026Today11/15/2026Fiscal Year End12/31/2026Next Earnings (Estimated)1/26/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:GNGBY CIKN/A Webwww.getinge.com Phone(610) 335-0000Fax46-1-033-556-40Employees11,670Year Founded1904Profitability EPS (Trailing Twelve Months)$1.10 Trailing P/E Ratio25.36 Forward P/E Ratio18.98 P/E GrowthN/ANet Income$230.87 million Net Margins8.20% Pretax Margin10.73% Return on Equity11.55% Return on Assets6.15% Debt Debt-to-Equity Ratio0.26 Current Ratio1.31 Quick Ratio0.74 Sales & Book Value Annual Sales$3.57 billion Price / Sales2.13 Cash Flow$1.98 per share Price / Cash Flow14.06 Book Value$11.07 per share Price / Book2.52Miscellaneous Outstanding Shares272,370,000Free FloatN/AMarket Cap$7.60 billion OptionableNot Optionable Beta0.89 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:GNGBY) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Getinge Please log in to your account or sign up in order to add this asset to your watchlist. Share Getinge With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.